Form 4 · Filed May 5, 2026, 09:00 PM UTC
TERN/Terns Pharmaceuticals, Inc.
Burroughs Amy L. — Chief Executive Officer
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a full AI thesis attached (deeper analysis on flagged buys).
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moDeep AI theses on flagged setups + cluster-buy alerts + insider-CIK watchlists.
- · Everything in Pro
- · Deep AI thesis on flagged buys
- · Cluster-buy alerts (multiple insiders, same ticker, short window)
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 5, 2026 | U | sell | 146,614 | $53 | $7,770,542 | 0 |
| May 5, 2026 | U | sell | 8,319 | $53 | $440,907 | 0 |
| May 5, 2026 | D | other | 150,000 | $53 | $7,950,000 | 0 |
| May 5, 2026 | D | other | 955,534 | — | — | 0 |
| May 5, 2026 | D | other | 1,250,000 | — | — | 0 |
| May 5, 2026 | D | other | 300,000 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001872564-26-000010